Sessions to focus on COVID-19

Scientific Sessions and the Resuscitation Science Symposium 2020 will present more than 23 sessions, featured both Live and OnDemand, dedicated to COVID-19 abstracts, clinical research, late-breaking science, workshops and presentations, and its impact on cardiovascular health. Featured guest speaker Anthony S. Fauci, MD, will present “COVID-19: Public Health and Scientific Challenges.”

Here are four key sessions that will be featured Live.

• AHA COVID-19 Rapid Response Research Consortium: Early Results: Speakers will reveal what’s hot, what we have learned about viral susceptibility and drugs, short- and long-term effects, management of myocardial injury and more. Other presentations will focus on hot topics and COVID-19 findings in other countries.
• AHA Goes Viral: COVID-19, Influenza Vaccines and Cardiovascular Disease: Speakers explore the AHA COVID-19 Cardiovascular Registry, racial and ethnic differences in treatment and outcomes, impact of cardiovascular disease on outcomes, high dose versus standard dose influenza vaccine in patients with high risk cardiovascular disease and more.
• Clinical and Public Health Impact of COVID-19 (International Focus): Colleagues on the front lines of the COVID pandemic in Australia/New Zealand, South Korea, China, Italy, Tanzania and Brazil provide insights on COVID-19, cardiovascular disease and outcomes.
• Launching and Advancing Careers in the Age of the Pandemic: Donna K. Arnett leads a discussion on building and advancing your career during the pandemic.

ReSS also will feature programming that addresses various aspects of COVID-19.

• Late-Breaking Resuscitation Science: This oral abstract presentation will discuss the impact of the COVID-19 pandemic on survival outcomes, the risk of COVID-19 illness among EMS providers following CPR and aerosol-generating procedures, in-hospital cardiac arrest in patients with COVID-19, how a faster time to elevation of the head and thorax during CPR increases the likelihood of return of spontaneous circulation after out-of-hospital cardiac arrest and how Tocilizumab reduces systemic inflammation and cardiac injury after out-of-hospital cardiac arrest.
• COVID-19 and its Impact on Cardiac Arrest Care: This lightning round oral abstract presentation addresses the COVID-19 pandemic’s impact on EMS runs and resuscitation attempts, the hidden impact of the COVID-19 pandemic on out-of-hospital cardiac arrest, the work of breathing scale to assess the need of intubation in COVID-19 pneumonia, the introduction of a mechanical chest compression device for in-hospital cardiac arrest during the COVID-19 pandemic and the outcomes for patients receiving CPR during the COVID-19 pandemic in the United States.
• CPR in the Era of COVID-19: Invited speaker Federico Semeraro, MD, Bologna, Italy, will present this topic during Plenary Session 2: Revisiting Basic Life Support.

For more specific programming, visit the online program planner’s COVID-19 community.

Register now for the best COVID-19 science.